Literature DB >> 32447043

The Impact of Antibiotic-Mediated Modification of the Intestinal Microbiome on Outcomes of Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis.

Maria Gavriilaki1, Ioanna Sakellari2, Achilles Anagnostopoulos2, Eleni Gavriilaki2.   

Abstract

Accumulating evidence points toward a protective role of intestinal microbiota diversity in allogeneic hematopoietic cell transplantation (allo-HCT). The purpose of this systematic review and meta-analysis is to determine the effect of antibiotic-mediated disruption of microbiota on main allo-HCT outcomes (graft-versus-host disease [GVHD], treatment-related mortality [TRM], overall survival [OS]). Following literature search, 2 reviewers screened eligible studies and assessed risk of bias (RoB). Meta-analysis was performed using Review Manager Software. Among 443 screened references, 18 were eligible for meta-analysis. In studies with genomic markers, grade II to IV acute GVHD was significantly reduced in patients not receiving gut decontamination (GD) (odds ratio [OR], 1.56; 95% confidence interval [CI], 1.20 to 2.04). In subgroup analysis, prophylaxis with systemic antibiotics conferred an increased risk of acute GVHD (OR, 1.65; 95% CI, 1.08 to 2.53). When we incorporated RoB, we found a positive correlation of intestinal GVHD with GD (OR, 1.77; 95% CI, 1.29 to 2.44). Patients with higher microbiota diversity presented increased OS (risk ratio [RR], 1.58; 95% CI, 1.19 to 2.09) and lower TRM (RR, 0.45; 95% CI, 0.26 to 0.76). Our findings confirm that GD and prophylaxis with systemic antibiotics increase acute and intestinal GVHD. Importantly, our meta-analysis was the first to show a significant effect of microbiota diversity on TRM and OS.
Copyright © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allogeneic hematopoietic cell transplantation; Graft-versus-host disease; Microbiota; Overall survival; Treatment-related mortality

Mesh:

Substances:

Year:  2020        PMID: 32447043     DOI: 10.1016/j.bbmt.2020.05.011

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  7 in total

Review 1.  The role of the thymus in allogeneic bone marrow transplantation and the recovery of the peripheral T-cell compartment.

Authors:  Enrico Velardi; Emmanuel Clave; Franco Locatelli; Antoine Toubert; Lucas C M Arruda; Francesca Benini
Journal:  Semin Immunopathol       Date:  2021-01-08       Impact factor: 9.623

2.  Sampling Multiple Catheter Lumens to Improve Detection of Bloodstream Infection in Pediatric Oncology Patients.

Authors:  Erica Rider; John A Ligon; Annie Voskertchian; Aaron M Milstone; Philip Toltzis
Journal:  J Pediatr Hematol Oncol       Date:  2022-03-01       Impact factor: 1.170

Review 3.  Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure.

Authors:  Mireia Uribe-Herranz; Nela Klein-González; Luis Gerardo Rodríguez-Lobato; Manel Juan; Carlos Fernández de Larrea
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

4.  Associations between the Gut Microbiota, Immune Reconstitution, and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Salvatore Fiorenza; Cameron J Turtle
Journal:  Immunometabolism       Date:  2021-01-12

Review 5.  Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment.

Authors:  Hui-Qing Chen; Jin-Yu Gong; Kai Xing; Mou-Ze Liu; Huan Ren; Jian-Quan Luo
Journal:  Front Med (Lausanne)       Date:  2022-01-19

Review 6.  The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD).

Authors:  Christos Demosthenous; Ioanna Sakellari; Vassiliki Douka; Penelope Georgia Papayanni; Achilles Anagnostopoulos; Eleni Gavriilaki
Journal:  J Clin Med       Date:  2021-05-11       Impact factor: 4.241

Review 7.  Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation.

Authors:  Sarah Lindner; Jonathan U Peled
Journal:  Curr Opin Hematol       Date:  2020-11       Impact factor: 3.218

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.